Phase 2–4 trials
MASH / liver disease · Live ClinicalTrials.gov data
Resmetirom (Rezdiffra) clinical trial pipeline
ClinicalTrials.gov lists 11 phase 2–4 trials for resmetirom (Rezdiffra), 3 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.
Phase 3 trials
Actively recruiting
Next phase 3 primary completion
Participants across trials
Lead sponsor by trial count
resmetirom
Upcoming readouts
8 ahead · resmetirom
Key resmetirom trials
Top 11 of the 11 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track resmetirom with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for resmetirom?
- ClinicalTrials.gov currently lists 11 phase 2–4 resmetirom trials: 5 phase 2, 4 phase 3, and 2 phase 4. 3 are actively recruiting.
- Are there clinical trials for Rezdiffra?
- Rezdiffra is the brand name for resmetirom, so resmetirom trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 11 phase 2–4 resmetirom trials: 5 phase 2, 4 phase 3, and 2 phase 4. 3 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare resmetirom against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.